TRex Bio, Inc. (TRXB)
NASDAQ: TRXB · Real-Time Price · USD
14.25
+1.12 (8.53%)
Nov 11, 2026, 4:00 PM EST - Market closed
TRex Bio Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
60
Market Cap
383.64M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 39.11M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
TRXB News
- 8 days ago - TRex Bio initiated with an Overweight at Cantor Fitzgerald - TheFly
- 9 days ago - TRex Bio initiated with an Overweight at JPMorgan - TheFly
- 9 days ago - TRex Bio initiated with a Buy at Stifel - TheFly
- 9 days ago - TRex Bio initiated with an Outperform at Wedbush - TheFly
- 4 weeks ago - TRexBio Announces Closing of Initial Public Offering - GlobeNewsWire
- 4 weeks ago - Opening Day: Biotech duo Retension, TRex Bio come public - TheFly
- 4 weeks ago - TRex Bio opens at $13.50, IPO priced at $14 per share - TheFly
- 4 weeks ago - TRex Bio indicated to open at $13.90, IPO priced at $14 - TheFly